Researchers from the University of Plymouth (UK) have developed and tested a deep learning model which, in a newly-published research study, has been shown to achieve up to 98% accuracy in distinguishing autistic from neurotypical participants. The researchers hope that, with further validation, their model could benefit autistic people - and the clinicians who assess and support them - by providing accurate, explainable insights to inform decisions.

Four out of five parents tell their donor-conceived children about their biological origins.

The current process for managing sexual misconduct perpetrated by doctors in the UK requires major reform, say experts in The BMJ today.

The largest study on pregnant women with excessive nausea and vomiting (hyperemesis gravidarum) has identified increased risks of numerous neuropsychiatric and mental health outcomes. 

New research shows that that the diabetes/obesity medication tirzepatide can cause clinically meaningful improvements in blood sugar control and weight loss in children and adolescents with type 2 diabetes aged 10-17 years whose diabetes and weight are inadequately controlled with an existing treatment regimen of metformin, insulin, or both.

The study (the SURPASS-PEDS trial), by Dr Tamara Hannon, Division of Pediatric Endocrinology and Diabetology, Indiana University School of Medicine, Indiana University School of Medicine, Indianapolis, USA, and colleagues is presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) and published in The Lancet. The study is sponsored by Eli Lilly and company, the manufacturer of tirzepatide.